Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer
Clinical trial NCT03170180 · COMPLETED
Trial details
- NCT number
- NCT03170180
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2021-10-31
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.